Search Filters

  • Presentation Format
  • Media Type
  • Diagnosis / Condition
  • Diagnosis Method
  • Patient Populations
  • Treatment / Technique

Autograft Versus Allograft For Medial Patellofemoral Ligament Reconstruction: A Systematic Review

Autograft Versus Allograft For Medial Patellofemoral Ligament Reconstruction: A Systematic Review

Gianna M. Aliberti, BA, UNITED STATES Matthew J. Kraeutler, MD, UNITED STATES Candence Miskimin, MS, UNITED STATES Anthony Scillia, UNITED STATES Mary K. Mulcahey, MD, UNITED STATES

Tulane University School of Medicine, New Orleans, LA, UNITED STATES


2021 Congress   ePoster Presentation     Not yet rated

 

Anatomic Location

Anatomic Structure

Diagnosis / Condition

Patient Populations

Sports Medicine

This media is available to current ISAKOS Members, Global Link All-Access Subscribers and Webinar/Course Registrants only.

Summary: Patients undergoing medical patellofemoral ligament (MPFL) reconstruction with either autograft or allograft can expect to experience improvement in clinical outcomes, though graft failure was more frequently observed in autograft patients.


Purpose

Patients with recurrent lateral patellar dislocations are often treated with reconstruction of the medial patellofemoral ligament (MPFL). The purpose of this study was to perform a systematic review to evaluate clinical outcomes and the risk of recurrent patellar dislocation following MPFL reconstruction with autograft versus allograft.

Methods

A systematic review was performed by searching PubMed, the Cochrane Library, and Embase to identify studies comparing outcomes of MPFL reconstruction (MPFLR) with autograft versus allograft. The search phrase used was "medial patellofemoral ligament reconstruction autograft allograft". The inclusion criteria were full-text studies that directly compared clinical outcomes and/or risk of recurrent patellar instability events between patients undergoing MPFL reconstruction with autograft versus allograft.

Results

Seven studies (one level II, three level III, three level IV) were identified that met inclusion criteria, including a total of 150 patients who underwent MPFL reconstruction with autograft and 193 with allograft. No difference was found within any particular study in terms of age, sex, body mass index (BMI), laterality, chronicity (acute versus chronic injury), or time from first patellar dislocation to surgery. Graft failure, defined as recurrent/subsequent dislocation, occurred in 13 autograft patients (13/150, 8.7%) and 6 allograft patients (6/193, 3.1%) (p=0.032). One study demonstrated no significant difference between tibial tubercle-trochlear groove distance (measured on magnetic resonance imaging) in failed versus successful grafts. One study found that patellar tilt angle improved significantly from preoperatively to postoperatively (p<0.001), but there was no difference between the groups. Kujala scores significantly improved for both autograft and allograft patients across studies. Two studies found significant differences in postoperative Kujala scores between the two groups, one of which found better scores in allograft patients (p=0.0032) and another in which scores were better in autograft patients (p=0.02).

Conclusion

Patients undergoing MPFL reconstruction with either autograft or allograft can expect to experience improvement in clinical outcomes. Graft failure was more frequently observed in autograft patients. Subjective outcomes improved to a similar degree in both groups. Allograft may be a better option for MPFLR due to lower failure rate.


More ISAKOS 2021: Global Content